Cross Country Healthcare Statistics
Total Valuation
CCRN has a market cap or net worth of $456.34 million. The enterprise value is $378.95 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CCRN has 32.78 million shares outstanding. The number of shares has decreased by -5.97% in one year.
Current Share Class | 32.78M |
Shares Outstanding | 32.78M |
Shares Change (YoY) | -5.97% |
Shares Change (QoQ) | -0.17% |
Owned by Insiders (%) | 5.51% |
Owned by Institutions (%) | 89.67% |
Float | 28.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 39.34 |
PS Ratio | 0.37 |
Forward PS | 0.36 |
PB Ratio | 1.09 |
P/TBV Ratio | 1.97 |
P/FCF Ratio | 4.10 |
P/OCF Ratio | 3.81 |
PEG Ratio | 3.96 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 37.31, with an EV/FCF ratio of 3.40.
EV / Earnings | n/a |
EV / Sales | 0.30 |
EV / EBITDA | 37.31 |
EV / EBIT | n/a |
EV / FCF | 3.40 |
Financial Position
The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.98 |
Quick Ratio | 2.90 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.26 |
Debt / FCF | 0.03 |
Interest Coverage | -3.29 |
Financial Efficiency
Return on equity (ROE) is -4.00% and return on invested capital (ROIC) is -1.04%.
Return on Equity (ROE) | -4.00% |
Return on Assets (ROA) | -0.76% |
Return on Invested Capital (ROIC) | -1.04% |
Return on Capital Employed (ROCE) | -1.60% |
Revenue Per Employee | $130,998 |
Profits Per Employee | -$1,847 |
Employee Count | 9,605 |
Asset Turnover | 2.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | -3.25M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.76% in the last 52 weeks. The beta is 0.38, so CCRN's price volatility has been lower than the market average.
Beta (5Y) | 0.38 |
52-Week Price Change | -6.76% |
50-Day Moving Average | 14.70 |
200-Day Moving Average | 15.01 |
Relative Strength Index (RSI) | 42.22 |
Average Volume (20 Days) | 252,614 |
Short Selling Information
The latest short interest is 2.55 million, so 7.79% of the outstanding shares have been sold short.
Short Interest | 2.55M |
Short Previous Month | 3.22M |
Short % of Shares Out | 7.79% |
Short % of Float | 8.92% |
Short Ratio (days to cover) | 10.29 |
Income Statement
In the last 12 months, CCRN had revenue of $1.26 billion and -$17.74 million in losses. Loss per share was -$0.55.
Revenue | 1.26B |
Gross Profit | 255.61M |
Operating Income | -7.47M |
Pretax Income | 16.60M |
Net Income | -17.74M |
EBITDA | 10.16M |
EBIT | -7.47M |
Loss Per Share | -$0.55 |
Full Income Statement Balance Sheet
The company has $80.70 million in cash and $3.31 million in debt, giving a net cash position of $77.39 million or $2.36 per share.
Cash & Cash Equivalents | 80.70M |
Total Debt | 3.31M |
Net Cash | 77.39M |
Net Cash Per Share | $2.36 |
Equity (Book Value) | 418.21M |
Book Value Per Share | 12.88 |
Working Capital | 216.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $119.79 million and capital expenditures -$8.39 million, giving a free cash flow of $111.40 million.
Operating Cash Flow | 119.79M |
Capital Expenditures | -8.39M |
Free Cash Flow | 111.40M |
FCF Per Share | $3.40 |
Full Cash Flow Statement Margins
Gross margin is 20.32%, with operating and profit margins of -0.59% and -1.41%.
Gross Margin | 20.32% |
Operating Margin | -0.59% |
Pretax Margin | -1.67% |
Profit Margin | -1.41% |
EBITDA Margin | 0.81% |
EBIT Margin | -0.59% |
FCF Margin | 8.85% |
Dividends & Yields
CCRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 5.97% |
Shareholder Yield | 5.97% |
Earnings Yield | -3.89% |
FCF Yield | 24.41% |
Analyst Forecast
The average price target for CCRN is $18.41, which is 32.26% higher than the current price. The consensus rating is "Buy".
Price Target | $18.41 |
Price Target Difference | 32.26% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CCRN has an Altman Z-Score of 5.07 and a Piotroski F-Score of 2.
Altman Z-Score | 5.07 |
Piotroski F-Score | 2 |